<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="apus-20251231.xsd" xlink:type="simple"/>
    <context id="cref_1579594117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894525</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1669847844">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001894525</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:RestatementDateAxis">
                    <ecd:RestatementDateAxis.domain>2025-12-31</ecd:RestatementDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <dei:DocumentType contextRef="cref_1579594117" id="fc_556764347">DEF 14A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="cref_1579594117" id="ixv-2668">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="cref_1579594117" id="ixv-2669">0001894525</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="cref_1579594117" id="ixv-2688">APIMEDS PHARMACEUTICALS US, INC.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="cref_1579594117" id="ixv-2689">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:ErrCompAnalysisTextBlock contextRef="cref_1669847844" id="ixv-973">&lt;p style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:24pt;widows:3;margin-top:8pt;"&gt;We have adopted an Executive Compensation Recovery Policy, which was filed as Exhibit 97.1 to our Annual Report on Form&#160;10&lt;span&gt;-K&lt;/span&gt; for the fiscal year ended December&#160;31, 2025.&lt;/p&gt;&lt;p style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:24pt;widows:3;margin-top:8pt;"&gt;Our Insider Trading Policy prohibits our directors and executive officers from engaging in hedging or monetization transactions or similar arrangements with respect to our securities, from buying or selling puts, calls or other derivative securities on our securities, and from holding our securities in a margin account or pledging our securities as collateral for a loan.&lt;/p&gt;</ecd:ErrCompAnalysisTextBlock>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="cref_1579594117" id="ixv-2012">&lt;p style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:24pt;widows:3;margin-top:8pt;"&gt; The Board and the Compensation Committee do not grant stock options on a predetermined schedule and do not take material nonpublic information into account when determining the timing or terms of option awards. We have not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. During 2025, we did not grant options to any named executive officer during the period beginning four&#160;business days before and ending one business&#160;day after the filing of a periodic report or a Current Report on Form&#160;8&lt;span&gt;-K&lt;/span&gt; disclosing material nonpublic information. &lt;/p&gt;</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgMethodTextBlock contextRef="cref_1579594117" id="ixv-2690">The Board and the Compensation Committee do not grant stock options on a predetermined schedule and do not take material nonpublic information into account when determining the timing or terms of option awards.</ecd:AwardTmgMethodTextBlock>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="cref_1579594117" id="ixv-2691">We have not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="cref_1579594117" id="ixv-2692">false</ecd:AwardTmgMnpiCnsdrdFlag>
</xbrl>
